179 related articles for article (PubMed ID: 37881505)
1. Risk Factors and Mortality of Elderly Patients with Hospital-Acquired Pneumonia of Carbapenem-Resistant
Zhou C; Sun L; Li H; Huang L; Liu X
Infect Drug Resist; 2023; 16():6767-6779. PubMed ID: 37881505
[TBL] [Abstract][Full Text] [Related]
2. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
Hsu JY; Chuang YC; Wang JT; Chen YC; Hsieh SM
J Formos Med Assoc; 2021 Nov; 120(11):1994-2002. PubMed ID: 33962811
[TBL] [Abstract][Full Text] [Related]
3. [Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality].
Büyüktuna SA; Hasbek M; Çelik C; Ünlüsavuran M; Avcı O; Baltacı S; Fırtına Topcu K; Elaldı N
Mikrobiyol Bul; 2020 Jul; 54(3):378-391. PubMed ID: 32755515
[TBL] [Abstract][Full Text] [Related]
4. The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.
Qin X; Wu S; Hao M; Zhu J; Ding B; Yang Y; Xu X; Wang M; Yang F; Hu F
J Infect Dis; 2020 Mar; 221(Suppl 2):S206-S214. PubMed ID: 32176790
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study.
Chen Y; Chen Y; Liu P; Guo P; Wu Z; Peng Y; Deng J; Kong Y; Cui Y; Liao K; Huang B
BMC Geriatr; 2022 Jul; 22(1):573. PubMed ID: 35831805
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Tertiary Care-Based Cohort Study on Clinical Characteristics and Outcomes of Ceftazidime-Avibactam-Resistant Carbapenem-Resistant
Ahmed F; Abraham B; Kamal Saeed N; Mohamed Naser H; Sridharan K
Crit Care Res Pract; 2024; 2024():3427972. PubMed ID: 38868174
[TBL] [Abstract][Full Text] [Related]
7. Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
Liu C; Liu L; Jin MM; Hu YB; Cai X; Wan L; Zhang HY; Li RY; Wu XJ
Curr Med Sci; 2022 Feb; 42(1):68-76. PubMed ID: 34985611
[TBL] [Abstract][Full Text] [Related]
8. Ceftazidime-Avibactam-Based Versus Tigecycline-Based Regimen for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae-Induced Pneumonia in Critically Ill Patients.
Shi Y; Hu J; Liu P; Wang T; Wang H; Liu Y; Cao Q; Zuo X
Infect Dis Ther; 2021 Dec; 10(4):2721-2734. PubMed ID: 34652713
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.
Kofteridis DP; Valachis A; Dimopoulou D; Maraki S; Christidou A; Mantadakis E; Samonis G
J Infect Chemother; 2014 May; 20(5):293-7. PubMed ID: 24703709
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant
Fang J; Li H; Zhang M; Shi G; Liu M; Wang Y; Bian X
Front Pharmacol; 2021; 12():780940. PubMed ID: 34955849
[No Abstract] [Full Text] [Related]
11. Risk Factors for and Clinical Outcomes of Carbapenem-Resistant
Zhang H; Guo Z; Chai Y; Fang YP; Mu X; Xiao N; Guo J; Wang Z
Infect Drug Resist; 2021; 14():1393-1401. PubMed ID: 33880044
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Carbapenem-resistant
Wang Z; Qin RR; Huang L; Sun LY
Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
[TBL] [Abstract][Full Text] [Related]
13. Retrospective Analysis of Epidemiology, Risk Factors, and Outcomes of Health Care-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in a Chinese Tertiary Hospital, 2010-2019.
Li M; Yang S; Yao H; Liu Y; Du M
Infect Dis Ther; 2023 Feb; 12(2):473-485. PubMed ID: 36520329
[TBL] [Abstract][Full Text] [Related]
14. Combination Therapy of Ceftazidime/Avibactam for the Treatment of Patients Infected with Carbapenem-Resistant Klebsiella pneumoniae: A Multicenter Retrospective Study.
Lin J; Zhang L; Zhou M; Tian X; Chen J; Lu M; Liu Z
Infect Dis Ther; 2023 Aug; 12(8):2165-2177. PubMed ID: 37653121
[TBL] [Abstract][Full Text] [Related]
15. In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae.
Huang W; Qiao F; Zhang Y; Huang J; Deng Y; Li J; Zong Z
Clin Infect Dis; 2018 Nov; 67(suppl_2):S225-S230. PubMed ID: 30423052
[TBL] [Abstract][Full Text] [Related]
16. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
[TBL] [Abstract][Full Text] [Related]
17. Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
Hussein K; Raz-Pasteur A; Finkelstein R; Neuberger A; Shachor-Meyouhas Y; Oren I; Kassis I
J Hosp Infect; 2013 Apr; 83(4):307-13. PubMed ID: 23313086
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of related factors of carbapenem resistant Klebsiella pneumoniae infection in patients with artificial airway].
Bian W; Chen W; Gu X; Wang S; Liu Y; Zhao G; Qin Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1324-1330. PubMed ID: 33463491
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P
Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.
Jiao Y; Qin Y; Liu J; Li Q; Dong Y; Shang Y; Huang Y; Liu R
Pathog Glob Health; 2015 Mar; 109(2):68-74. PubMed ID: 25707874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
